Form 4: Axogen Director Alan M. Levine Reports Stock Vesting

Alan M. Levine, a director of Axogen, Inc., reported the vesting of 11,904 restricted stock units on September 1, 2024, resulting in ownership of 40,816 common stock shares.

Summary

• On September 1, 2024, Alan M. Levine, a director at Axogen, Inc., had 11,904 restricted stock units vest.
• These units converted into 11,904 shares of Axogen common stock.
• The vesting occurred as part of an annual equity grant for service as a Director on the Axogen, Inc. Board of Directors.
• The number of shares was determined based on a $150,000 valuation as of the grant date.
• Following this transaction, Levine beneficially owns 40,816 shares of Axogen common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock vesting, which is a normal part of executive compensation. There's no indication of unusual activity or concern.

Positives

• The vesting of restricted stock units indicates continued service and commitment by the director to Axogen.
• The equity grant aligns the director's interests with those of the shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The vesting of stock units aligns the director's interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates